ArticleACS omega2020
Deep Eutectic Solvent-Assisted Synthesis of Au Nanostars Supported on Graphene Oxide as an Efficient Substrate for SERS-Based Molecular Sensing.
Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 31 citations in OpenAlex.
- Plasmonic Hybrid Heterostructure Based on Reduced Graphene Oxide-Gold Nanostars Composite for Sensitive Surface-Enhanced Raman Spectroscopy Sensing.Applied spectroscopy · 2025Article
- Deep Eutectic Solvent-Assisted Synthesis of Ni-Graphene Composite Supported on Screen-Printed Electrodes for Biogenic Amine Detection.Materials (Basel, Switzerland) · 2025Article
- Ultrasensitive SERS substrate for label-free therapeutic drug monitoring of chlorpromazine hydrochloride and aminophylline in human serum.Analytical and bioanalytical chemistry · 2023Article
- Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy.Acta pharmaceutica Sinica. B · 2023Article
- Au Nanorods on Carbon-Based Nanomaterials as Nanohybrid Substrates for High-Efficiency Dynamic Surface-Enhanced Raman Scattering.ACS omega · 2022Article
- Plasmonic Metal Nanoparticles Hybridized with 2D Nanomaterials for SERS Detection: A Review.Biosensors · 2022Review
- Direct Laser Writing of Copper Micropatterns from Deep Eutectic Solvents Using Pulsed near-IR Radiation.Nanomaterials (Basel, Switzerland) · 2022Article
- Long Spiky Au-Ag Nanostar Based Fiber Probe for Surface Enhanced Raman Spectroscopy.Materials (Basel, Switzerland) · 2022Article
- Mixed-Dimensional Heterostructure Material-Based SERS for Trace Level Identification of Breast Cancer-Derived Exosomes.ACS omega · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of hybrid nanostructures of graphene oxide (GO) and metal nanoparticles (NPs) is of paramount interest for highly flexible surface-enhanced Raman scattering (SERS) substrate-based molecular sensing. In this work, we report a simple and eco-friendly synthesis strategy for the synthesis of a three-dimensional (3D) GO/gold nanostar (3D GO/Au NS) hybrid nanocomposite using deep eutectic solvent (DES) for SERS-based molecular sensing. The 3D GO/Au NS hybrid nanocomposite was obtained by a two-step synthetic process. In the first step, the GO nanosheets of thickness ∼1.25 nm were homogeneously dispersed in choline chloride/urea (molar ratio of 1:2)-derived DES, followed by functionalization of -NH groups using 3-aminopropyltriethoxysilane. Afterward, the presynthesized Au NSs of size ranging between 150-200 nm were then covalently attached on the -NH-functionalized GO nanosheets mediated by DES at 60 °C to obtain 3D GO/Au NS hybrid nanocomposites. Importantly, the SERS substrate fabricated using the 3D GO/Au NS hybrid nanocomposite exhibits highly enhanced SERS activity with an enhancement factor of 1.7 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.